Literature DB >> 15500627

Immunosuppression, interleukin-10 synthesis and apoptosis are induced in rats inoculated with Cryptococcus neoformans glucuronoxylomannan.

Laura S Chiapello1, José L Baronetti, María P Aoki, Susana Gea, Héctor Rubinstein, Diana T Masih.   

Abstract

Glucuronoxylomannan (GXM) is the major Cryptococcus neoformans capsular polysaccharide and represents the main virulence factor of this fungus. In in vitro studies we have demonstrated previously that this acidic and high-molecular-weight polysaccharide suppresses lymphoproliferation, modulates cytokine production and promotes apoptosis in spleen mononuclear (Spm) cells from rats. In this study we demonstrate that these phenomena also occur in vivo after the intracardiac inoculation of GXM into normal Wistar rats. The results of this study show suppression of the proliferative response Spm cells to concanavalin A (Con A) or heat-killed C. neoformans (HKCn) in the first 2 weeks after polysaccharide administration. In addition, increased levels of interleukin (IL)-10 were produced by Con A-stimulated Spm cells, coinciding with immunohistochemical GXM detection in the white pulp of spleen. In particular, high production of IL-10 with diminution of IL-2, interferon (IFN)-gamma and tumour necrosis factor (TNF)-alpha synthesis were detected 14 days after GXM administration. In situ cell death detection by TdT-mediated biotin-dUTP nick-end labelling (TUNEL) reaction in sections of spleen, lung and liver demonstrates apoptosis in tissues with deposits of GXM. These data demonstrate the in vivo ability of GXM to modify cytokine synthesis by Spm cells and to promote host cell apoptosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15500627      PMCID: PMC1782585          DOI: 10.1111/j.1365-2567.2004.01970.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  56 in total

Review 1.  Virulence factors of Cryptococcus neoformans.

Authors:  T R Kozel
Journal:  Trends Microbiol       Date:  1995-08       Impact factor: 17.079

Review 2.  Nuclear changes in apoptosis.

Authors:  W C Earnshaw
Journal:  Curr Opin Cell Biol       Date:  1995-06       Impact factor: 8.382

3.  Cryptococcal antigen detection from the urine of AIDS patients.

Authors:  K Chapin-Robertson; C Bechtel; S Waycott; C Kontnick; S C Edberg
Journal:  Diagn Microbiol Infect Dis       Date:  1993-10       Impact factor: 2.803

4.  Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody.

Authors:  D L Goldman; S C Lee; A Casadevall
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

5.  T-cell-dependent and T-cell-independent mechanisms of tolerance to glucuronoxylomannan of Cryptococcus neoformans serotype A.

Authors:  J B Sundstrom; R Cherniak
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

6.  Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat.

Authors:  D Goldman; S C Lee; A Casadevall
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

7.  Protective murine monoclonal antibodies to Cryptococcus neoformans.

Authors:  J Mukherjee; M D Scharff; A Casadevall
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

8.  Biochemical basis for the killing of Cryptococcus neoformans by rat peritoneal cells.

Authors:  G R Rossi; D A Sastre; H R Rubinstein; D T Masih
Journal:  J Med Vet Mycol       Date:  1994-12

9.  Intravascular cryptococcal culture filtrate (CneF) and its major component, glucuronoxylomannan, are potent inhibitors of leukocyte accumulation.

Authors:  Z M Dong; J W Murphy
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

10.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

Authors:  Y Gavrieli; Y Sherman; S A Ben-Sasson
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

View more
  16 in total

1.  Capsular Material of Cryptococcus neoformans: Virulence and Much More.

Authors:  A Vecchiarelli; C Monari
Journal:  Mycopathologia       Date:  2012-02-08       Impact factor: 2.574

2.  Rat eosinophils stimulate the expansion of Cryptococcus neoformans-specific CD4(+) and CD8(+) T cells with a T-helper 1 profile.

Authors:  Ana P Garro; Laura S Chiapello; José L Baronetti; Diana T Masih
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

Review 3.  Immune response and immunotherapy to Cryptococcus infections.

Authors:  Qing Zhou; William J Murphy
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  The effect of the expression of virulence-associated DEAD-box RNA helicase mRNA on the imbalance of Th1-Th2 cytokines in the CSF of patients with Cryptococcus neoformans meningitis.

Authors:  L Jiang; N Lin; Z Cheng; B Yang; Q Ou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-13       Impact factor: 3.267

5.  Extracellular vesicles from Cryptococcus neoformans modulate macrophage functions.

Authors:  Débora L Oliveira; Célio G Freire-de-Lima; Joshua D Nosanchuk; Arturo Casadevall; Marcio L Rodrigues; Leonardo Nimrichter
Journal:  Infect Immun       Date:  2010-02-09       Impact factor: 3.441

6.  Eosinophils elicit proliferation of naive and fungal-specific cells in vivo so enhancing a T helper type 1 cytokine profile in favour of a protective immune response against Cryptococcus neoformans infection.

Authors:  Ana P Garro; Laura S Chiapello; Jose L Baronetti; Diana T Masih
Journal:  Immunology       Date:  2011-10       Impact factor: 7.397

7.  Differential activation of peritoneal cells by subcutaneous treatment of rats with cryptococcal antigens.

Authors:  José L Baronetti; Laura S Chiapello; Ana P Garro; Diana T Masih
Journal:  Clin Vaccine Immunol       Date:  2009-06-03

Review 8.  The capsule of the fungal pathogen Cryptococcus neoformans.

Authors:  Oscar Zaragoza; Marcio L Rodrigues; Magdia De Jesus; Susana Frases; Ekaterina Dadachova; Arturo Casadevall
Journal:  Adv Appl Microbiol       Date:  2009       Impact factor: 5.086

9.  Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannan.

Authors:  Kausik Datta; Andrew Lees; Liise-anne Pirofski
Journal:  Clin Vaccine Immunol       Date:  2008-06-04

10.  Chitin-like molecules associate with Cryptococcus neoformans glucuronoxylomannan to form a glycan complex with previously unknown properties.

Authors:  Caroline L Ramos; Fernanda L Fonseca; Jessica Rodrigues; Allan J Guimarães; Leonardo P Cinelli; Kildare Miranda; Leonardo Nimrichter; Arturo Casadevall; Luiz R Travassos; Marcio L Rodrigues
Journal:  Eukaryot Cell       Date:  2012-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.